Business Telegraph

.
The Times Real Estate

.

Esco Lifesciences Group and Allwin Medical Devices Announce Strategic Partnership

  • Written by Telegraph Magazine

SINGAPORE and ANAHEIM, USA - Media Outreach Newswire - 25 February 2025 - Allwin Medical Devices Inc. ("Allwin"), a leading manufacturer of a wide range of medical devices addressing women's health (IVF), urology, gastroenterology and interventional radiology has partnered with Esco, a leading global provider of life sciences equipment that serves multiple global markets including the in vitro fertilization (IVF) market, via a strategic partnership.

Financial terms were not disclosed.

Esco Lifesciences Group and Allwin Medical Deal Signing, 13 February 2025
Esco Lifesciences Group and Allwin Medical Deal Signing, 13 February 2025

Strategic Partnership Rationale

  • The IVF consumables portfolio of Allwin Medical will expand Esco's IVF instrument portfolio, and the combined product portfolio will have a complementary balance between consumables and instruments.
  • IVF clinicians and embryologists who use either Allwin's consumables or Esco's time lapse or standard IVF incubators will have access to a more complete workflow solution.
  • The strong sales and operational presence of Allwin Medical in India will serve Esco well by providing the company with an established base and strong presence in the country, one of the largest and fastest growing economies in the world.
  • Most significantly, the management and personnel of Allwin Medical have demonstrated exceptional talent, acumen, and expertise in the IVF consumables market. Their ongoing contributions to the advancement and success of Allwin Medical is highly valued.

XQ Lin, Chief Executive Officer of Esco, said, "Infertility is a problem that has social, psychological, and economic impacts to the afflicted individuals and couples. It has been estimated that 1 in 6 couples will struggle with infertility at least once in their lifetime. This transaction brings together two companies intent on accelerating innovation for our IVF customers and enabling dreams of couples around the world. Through Esco Medical, our IVF medical devices business unit, Esco Lifesciences Group provides comprehensive ART workflow solutions to IVF clinics, laboratories, and research centers worldwide. Our integrated portfolio, including Time-Lapse Incubators, IVF Workstations, and a witnessing and traceability system designed in Denmark and manufactured in Europe, streamlines processes and optimizes outcomes. With our majority stake, strategic investment in Allwin, we will be in a strong position to fulfill our companies' missions of enabling our customers to make the world healthier, more equitable, and resilient."

Dhiren Mehta, Chief Executive Officer and founder of Allwin Medical, noted, "Allwin's mission since our inception has been to deliver high quality, innovative, and reliable product to laboratories in the IVF/ART and urology markets. We enable our customers to deliver better outcomes to patients globally. By partnering with Esco, we expect to be well-positioned to better serve our customers' needs worldwide. With Allwin we All Win!"

Dr. Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, and a member of Esco's Board of Directors, added, "Novo Holdings has been a strong supporter of Esco since our investment in 2021. The strategic investment in Allwin provides a meaningful growth opportunity for Esco. We are confident that the partnership with the Allwin team and expansion of Esco's presence in IVF consumables and India will serve both companies well."

Advisors
Forvis Mazars served as exclusive financial advisor to the Esco Lifesciences Group. IndusLaw and Finn Dixon & Herling LLP served as legal advisors to the Esco Lifesciences Group. Confluentia Advisors served as exclusive financial advisor to Allwin Medical. Khaitan & Co and Bryan Cave Leighton Paisner LLP served as legal advisors to Allwin Medical.


Hashtag: #EscoLifesciencesGroup #EscoMedical #Esco #AllwinMedical #Allwin #StrategicInvestment #IVF #MedicalDevices #AssistedReproductionTechnlogies








The issuer is solely responsible for the content of this announcement.

About Allwin Medical

Allwin Medical is a leading manufacturer of a wide range of medical devices including Women's Health (IVF) and Urology. Headquartered in Anaheim, California, USA, the company is committed to providing its customers with high quality devices. Its products are sold in 90+ countries globally through a network of 100+ distributors that cater to global markets. Within India, 100+ dealers support and promote sales for the Indian market. Founded in 2006 by Dhiren Mehta who has more than 35+ years of experience in the medical device industry, the company has exhibited consistent and strong growth.

For more information about Allwin Medical:

About Esco Lifesciences Group

Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries.

Esco, through its business unit Esco Medical, leads in delivering comprehensive workflow solutions for assisted reproduction technologies (ART) to IVF clinics, laboratories, and research centers worldwide.

For more information about Esco Lifesciences Group:

Entrepreneurs & Leaders

Blocked Drains Sydney: What Every Property Manager Should Know (Before It’s Too Late)

Let’s be honest—blocked drains aren’t the kind of thing anyone wants to deal with. But if you’re managing a property, ...

Design Without Designers: How AI Tools Build Visually Stunning Landing Pages

Before now, the average person would have to hire a designer, spend hours, and sometimes even require an entire creati...

Argent Biopharma (ASX:RGT) Lands European Approval — Market Reaction Begins

Most investors scroll past microcap biotech stocks, assuming they’re years away from anything real. But Argent Biophar...

SMTP Error 451: Temporary Local Problem But Is It Yours or Theirs?

SMTP error 451 is one of those frustrating mistakes that exist in a fuzzy realm between sender and receiver responsibi...

How Headless CMS Improves A/B Testing Capabilities for Content Optimization

A/B testing is one of the best ways to boost content engagement, increase conversion rates, and improve user experience...

A Clean Car Park Equals Happy Customers: The Impact of Professional Sweeping

First impressions matter, and a clean car park can enhance customer experience. Discover how regular sweeping services h...

Authenticity in Marketing: Why It Matters More Than Ever for Businesses

(featured image) Marketing has always been connecting with people, but let’s be honest—consumers are more sceptical tha...

Crypto Expert John Fenga asks: Can Green Cryptocurrencies Make a Difference?

Cryptocurrencies have transformed financial systems, enabling decentralised, borderless transactions. However, their ...

How to Choose the Best Web Design for Your Website in Melbourne?

Today, your website serves as a crucial touchpoint for potential customers. It's often the first interaction someone h...